Benzinga's Volume Movers
Cancer Genetics (NASDAQ: CGIX) shares moved up 6.38% to $20.85. The volume of Cancer Genetics shares traded was 1637% higher than normal. Cancer Genetics is expected to post revenue of $ 18.65 million in the year ending December, 2014.
Global Payments (NYSE: GPN) shares rose 9.25% to $55.39. The volume of Global Payments shares traded was 1130% higher than normal. Global Payments reported upbeat fiscal first-quarter results and raised its annual forecast. The company named Jeffrey S. Sloan as its new chief executive and announced its plans to buy back up to $100 million of its common stock.
Rockwell Medical (NASDAQ: RMTI) shares climbed 7.69% to $12.32. The volume of Rockwell Medical shares traded was 482% higher than normal. Rockwell Medical reported that the Phase 3 CRUISE study data has been accepted as a Late-Breaking Clinical Trial.
Allot Communications (NASDAQ: ALLT) surged 11.80% to $14.12. The volume of Allot Communications shares traded was 459% higher than normal. Allot Communications reported that it has received a new multimillion dollar order from a US-based cloud provider.
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.